3279 First in Man
Laura Adang(Children's Hospital of Philadelphia), Nicole Ulrick(Children's Hospital of Philadelphia), Kyle Peer(University of Pennsylvania), Jessica Galli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Jamie Koh(Children's Hospital of Philadelphia), Simona Orcesi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Francesco Gavazzi(Children's Hospital of Philadelphia), Elisa Fazzi(Centro Studi GISED), Valentina De Giorgis(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Julia Kramer-Golinkoff(Children's Hospital of Philadelphia), Micaela De Simone(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)
Cited by 0
Related Papers
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Fetal Myelomeningocele Repair: The Post-MOMS Experience at the Children's Hospital of Philadelphia
|Fetal Diagnosis and Therapy|2014|212
Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
|New England Journal of Medicine|2020|201
cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing
|Nature Genetics|2020|199
Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function
|Human Mutation|2020|115